Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2012 | Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents. | Cheng, T. -J. R.; Weinheimer, S.; Tarbet, E. B.; Jan, J. -T.; Cheng, Y. -S. E.; Shie, J. -J.; Chen, C. -L.; Chen, C. -A.; Hsieh, W. -C.; Huang, P. -W.; Lin, W. -H.; Wang, S. -Y.; Fang, J. -M.; Hu, O. Y. -P.; Wong, C. -H. | Journal of medicinal chemistry 55(20), 8657-70 | | | |
2008 | Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics | Cheng, T. -J. R.; Sung, M. -T.; Liao, H. -Y.; Chang, Y. -F.; Chen, C. -W.; Huang, C. -Y.; Chou, L. -Y.; Wu, Y. -D.; Chen, Y. -H.; Cheng, Y. -S. E.; Wong, C. -H.; Ma, C.; Cheng, W. -C. | Proceedings of the National Academy of Sciences of the United States of America 105, 431-436 | | | |
2011 | E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors | Shen, Y. -F.; Chen, Y. -H.; Chu, S. -Y.; Lin, M. -I.; Hsu, H. -T.; Wu, P. -Y.; Wu, C. -J.; Liu, H. -W.; Lin, F. -Y.; Lin, G.; Hsu, P. -H.; Yang, A. -S. ; Cheng, Y. -S. E.; Wu, Y. -T.; Wong, C. -H. ; Tsai, M. -D. | Proceedings of the National Academy of Sciences of the United States of America 108(40), 16515-16520 | | | |
2012 | Enhanced Anti-influenza Agents Conjugated with Anti-inflammatory Activity. | Liu, K. -C.; Fang, J. -M.; Jan, J. -T.; Cheng, T. -J. R.; Wang, S. -Y.; Cheng, Y. -S. E.; Tsai, K. -C.; Yang, A. -S.; Wong, C. -H. | Journal of medicinal chemistry 55(19), 8493-501 | | | |
2010 | High-Throughput Identification of Antibacterials against Methichillin-Resistant Staphylococcus Aureus (MRSA) and the Transglycosylase | Cheng, T. -J. R.; Wu, Y. -T.; Yang, S. -T.; Loh, A.; Chen, S. -K.; Chen, Y. -H.; Huang, W. -I.; Yuan, C. -H.; Shih, H. -W.; Cheng, Y. -S. E.; Cheng, W. -C.; Wong, C. -H. | BIOORGANIC & MEDICINAL CHEMISTRY 18(24), 8512-8529 | | | |
2010 | High-throughput Identification of Compounds Targeting Influenza RNA-dependent RNA Polymerase Activity | Su, C. -Y.; Cheng, T. -J. R.; Lin, M. -I.; Wang, S. -Y.; Huang, W. -I.; Lin-Chu, S. -Y.; Chen, Y. -H.; Wu, C. -Y.; Lai, M. M. C. ; Cheng, W. -C.; Wu, Y. -T.; Tsai, M. -D. ; Cheng, Y. -S. E.; Wong, C. -H. | Proceedings of the National Academy of Sciences of the United States of America 107(45), 19151-19156 | | | |
2008 | In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses | Su, C. -Y.; Wang, S. -Y.; Shie, J. -J.; Jeng, K. -S.; Temperton, N. J.; Fang, J. -M.; Wong, C. -H.; Cheng, Y. -S. E. | ANTIVIRAL RESEARCH 79(3), 199-205 | | | |
2010 | In vivo protection of bacterial and viral infections in murine models using a synthetic new {alpha}-GalCer analog. | Lin, K. -H.; Liang, J. -J.; Huang, W. -I.; Lin-Chu, S. -Y.; Su, C. -Y.; Lee, Y. -L.; Jan, J. -T.; Lin, Y. -L.; Cheng, Y. -S. E.; Wong, C. -H. | Antimicrobial agents and chemotherapy 54(10), 4129-4136 | | | |
2011 | Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir | Liu, K. -C.; Lee, P. -S.; Wang, S. -Y.; Cheng, Y. -S. E.; Fang, J. -M.; Wong, C. -H. | BIOORGANIC & MEDICINAL CHEMISTRY 19(16), 4796-4802 | | | |
2009 | Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus. | Wen, W. -H.; Lin, M.; Su, C. -Y.; Wang, S. -Y.; Cheng, Y. -S. E.; Fang, J. -M.; Wong, C. -H. | Journal of medicinal chemistry 52(15), 4903-4910 | | | |